Nea Management Company, LLC Aurinia Pharmaceuticals Inc. Transaction History
Nea Management Company, LLC
- $1.43 Billion
- Q1 2024
A detailed history of Nea Management Company, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Nea Management Company, LLC holds 3,969,834 shares of AUPH stock, worth $22.7 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
3,969,834
Previous 3,969,834
-0.0%
Holding current value
$22.7 Million
Previous $35.7 Million
44.27%
% of portfolio
1.4%
Previous 2.6%
Shares
4 transactions
Others Institutions Holding AUPH
# of Institutions
205Shares Held
55.6MCall Options Held
838KPut Options Held
1.18M-
Armistice Capital, LLC New York, NY12.3MShares$70 Million0.84% of portfolio
-
Black Rock Inc. New York, NY8.66MShares$49.5 Million0.0% of portfolio
-
State Street Corp Boston, MA2.77MShares$15.8 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.15MShares$12.3 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL2.06MShares$11.8 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $810M
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...